Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
11.61 Up 1.33(12.94%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:10.28
Open:10.25
Bid:10.90 x 100
Ask:11.88 x 8000
1y Target Est:29.50
Beta:0.94
Next Earnings Date:15-May-14GALT Earnings announcement
Day's Range:10.05 - 11.82
52wk Range:3.80 - 19.11
Volume:564,960
Avg Vol (3m):602,714
Market Cap:254.63M
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALTUp 12.94%254.63M
MNTADown 3.98%568.56M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.83
Quarterly EPS Est (Mar-14) :-0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback